Mercer Global Advisors
BCAB icon

Mercer Global Advisors’s BioAtla BCAB Stock Holding History

Mercer Global Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8 Buy
+2
New +$8 ﹤0.01% 6066

Other funds holding BCAB

Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Mercer Global Advisors's BCAB Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in BioAtla (BCAB) in Q2 2026: 2 shares worth $8. The stake represents ﹤0.01% of the portfolio and ranks #6066 among its holdings.

7 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Mercer Global Advisors held 2 shares of BioAtla worth $8 as of Q2 2026.
  • BioAtla was a new Mercer Global Advisors position in Q2 2026.
  • BioAtla made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6066 holding.
  • 7 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.